LONDON — Britain’s panel of vaccine advisers on Friday said that people under 40 should be offered an alternative to Oxford/AstraZeneca’s COVID-19 shot where possible, due to a small risk from rare blood clots.
The Joint Committee on Vaccination and Immunization (JCVI) broadened the age range of people who should be offered alternatives to include people aged 30-39. Previously, advice was only for people under 30 to be offered an alternative vaccine.
AstraZeneca’s COVID-19 shot, developed by Oxford, has resulted in reports of rare blood clots with low platelet levels that occur more commonly in younger adults, with several countries advising the shot is given only to older pe…
Keep on reading: UK advises under-40s to take alternative to AstraZeneca COVID-19 shot